Alvogen is expanding its presence in Asia by licensing a novel oral contraceptive from Belgium’s Mithra and striking a deal to market Orion’s Parkinson’s disease drugs.
Alvogen is expanding its women’s health presence in Asia by securing an exclusive license to commercialize Mithra Pharmaceuticals’ Estelle (estetrol/drospirenone) combination oral contraceptive in Hong Kong and Taiwan.
Under the terms of the 20-year license and supply agreement, Alvogen will distribute Estelle in Hong Kong and Taiwan “where...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
